OncoCyte Co. (NASDAQ:OCX – Get Rating) saw a significant increase in short interest in the month of May. As of May 31st, there was short interest totalling 1,420,000 shares, an increase of 22.4% from the May 15th total of 1,160,000 shares. Based on an average daily trading volume, of 531,600 shares, the days-to-cover ratio is […]
StockNews.com started coverage on shares of OncoCyte (NASDAQ:OCX – Get Rating) in a report published on Sunday morning. The firm issued a sell rating on the stock. Separately, Needham & Company LLC dropped their target price on shares of OncoCyte from $1.40 to $0.45 and set a buy rating on the stock in a report […]
StockNews.com started coverage on shares of OncoCyte (NASDAQ:OCX – Get Rating) in a report released on Friday. The brokerage issued a sell rating on the stock. Separately, Needham & Company LLC decreased their target price on shares of OncoCyte from $1.40 to $0.45 and set a buy rating on the stock in a research report […]
StockNews.com started coverage on shares of OncoCyte (NYSE:OCX – Get Rating) in a research note published on Friday. The firm issued a sell rating on the stock. OncoCyte Stock Down 2.1 % OCX opened at $0.22 on Friday. OncoCyte has a fifty-two week low of $0.20 and a fifty-two week high of $1.35. OncoCyte (NYSE:OCX […]
StockNews.com assumed coverage on shares of OncoCyte (NASDAQ:OCX – Get Rating) in a report published on Friday. The brokerage issued a sell rating on the stock. Separately, Needham & Company LLC cut their price objective on OncoCyte from $1.40 to $0.45 and set a buy rating on the stock in a report on Tuesday, April […]